In this study, we find that in absence of PRMT2 in AML cells, the canonical NF-κB signaling pathway is overactivated, resulting in the induction of its target genes such as IL6, promoting the JAK/STAT3 pathway through the binding of IL6 to its receptor. The gene discussed is PRMT2; the disease is acute myeloid leukemia.